-
1
Carotid artery stenosis is a major cause of stroke, with CEA, CAS, and TCAR as primary revascularization procedures to reduce long-term stroke risk.
-
2
A study of nearly 150,000 patients in France found that CEA had a lower 30-day stroke or death risk compared to CAS for both asymptomatic and symptomatic patients.
-
3
The study reported 98% postoperative medical therapy compliance, indicating that high adherence rates can be achieved in real-world practice.
-
4
Observational studies like this one highlight potential disparities in outcomes compared to randomized trials, raising questions about generalizability.
-
5
The findings suggest that CEA may offer superior stroke outcomes compared to CAS, contributing to ongoing debates about optimal treatment for carotid disease.